Measuring Medication Adherence in a Population-Based Asthma Administrative Pharmacy Database: A Systematic Review and Meta-Analysis

References

• Wang S, Huang Z, Traubenberg S. Measuring Medication Adherence with Simple Drug Use and Medication Switching. SAS Glob Forum; 2013:1–9.
   Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x22486599
   PubMed Web of Science ®Google Scholar
• Mäkelä M, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.00523643487
   PubMed Web of Science ®Google Scholar
• Bender B, Milgrom H, Apter A. Adherence intervention research: what have we learned and what do we do next? J Allergy Clin Immunol. 2003;112(3):489–494. doi:10.1016/S0091-6749(03)01718-413679805
   PubMed Web of Science ®Google Scholar
• Lindsay J, Heaney L. Nonadherence in difficult asthma - facts, myths, and a time to act. Patient Prefer Adherence. 2013;7:329–336.23723690
   PubMed Web of Science ®Google Scholar
• Bateman E, Hurd S, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–178. doi:10.1183/09031936.0013870718166595
   PubMed Web of Science ®Google Scholar
• Bender B, Bender S. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am. 2005;25:107–130. doi:10.1016/j.iac.2004.09.00515579367
   PubMed Web of Science ®Google Scholar
• Rand C, Wise R. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149:S69–S76. doi:10.1164/ajrccm/149.2_Pt_2.S698298770
   PubMed Web of Science ®Google Scholar
• Williams L, Joseph C, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007;120:1153–1159. doi:10.1016/j.jaci.2007.08.02017936894
   PubMed Web of Science ®Google Scholar
• Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117–122.31086837
   PubMedGoogle Scholar
• Engelkes M, Janssens HM, De Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. doi:10.1183/09031936.0007561425323234
   PubMed Web of Science ®Google Scholar
• Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565–574. doi:10.1002/pds.123016514590
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:1–12.
   Web of Science ®Google Scholar
• Ismaila A, Corriveau D, Vaillancourt J, et al. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Curr Med Res Opin. 2014;30(7):1417–1425. doi:10.1185/03007995.2014.90882724666139
   PubMed Web of Science ®Google Scholar
• Friedman HS, Navaratnam P, McLaughlin J. Treatment and outcomes - adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. J Asthma. 2010;47(9):994–1000. doi:10.1080/02770903.2010.51307620831468
   PubMed Web of Science ®Google Scholar
• Karve S, Cleves M, Helm M, Hudson T, West D, Martin B. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health. 2009;12(6):989–995. doi:10.1111/j.1524-4733.2009.00543.x19402852
   PubMed Web of Science ®Google Scholar
• Williams LK, Pladevall M, Xi H. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288–1293. doi:10.1016/j.jaci.2004.09.02815577825
   PubMed Web of Science ®Google Scholar
• Kang HR, Song HJ, Nam JH, et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 2018;8(3):1–10. doi:10.1136/bmjopen-2017-020825
   Web of Science ®Google Scholar
• Bidwal M, Lor K, Yu J, Ip E. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center. Res Soc Adm Pharm. 2017;13(4):759–766. doi:10.1016/j.sapharm.2016.07.007
   PubMed Web of Science ®Google Scholar
• Farmer K. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. ClinicalTherapeutics. 1999;21(6):1074–1090.
   Google Scholar
• Stanford RH, Averell C, Parker ED, Blauer-Peterson C, Reinsch TK, Buikema AR. Assessment of adherence and asthma medication ratio for a once-daily and twice-daily inhaled corticosteroid/long-acting β-agonist for asthma. J Allergy Clin Immunol Pract. 2019;7(5):1488–1496.e7. doi:10.1016/j.jaip.2018.12.02130639604
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Ltman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b253519622551
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10. doi:10.1186/s13643-016-0384-426729230
   PubMedGoogle Scholar
• Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris EM, editor. Z: Joanna Briggs Institute Reviewer’s Manual. Adelaide, South Australia: The Joanna Briggs Institute; 2017.
   Google Scholar
• Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE handbook: handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach, Cochrane collaboration, London, United Kingdom; 2013. Available from: https://gdt.gradepro.org/app/handbook/handbook.html. Accessed October 6, 2021.
   Google Scholar
• Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme version. Bailrigg Lancaster Univ. 2006;1:1–92.
   Google Scholar
• Darbà J, Ramírez G, Sicras A, García-Bujalance L, Torvinen S, Sánchez-de La Rosa R. Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance. Patient Prefer Adherence. 2016;10:135–145. doi:10.2147/PPA.S9530326929605
   PubMed Web of Science ®Google Scholar
• Delea TE, Stanford RH, Hagiwara M, Stempel DA. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs. Curr Med Res Opin. 2008;24(12):3435–3442. doi:10.1185/0300799080255734419032125
   PubMed Web of Science ®Google Scholar
• Feehan M, Ranker L, Durante R, et al. Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain. J Clin Pharm Ther. 2015;40(5):590–593. doi:10.1111/jcpt.1231626291693
   PubMed Web of Science ®Google Scholar
• Gelzer AD, Gao W, Keleti D, et al. Multifaceted interventions improve medication adherence and reduce acute hospitalization rates in Medicaid patients prescribed asthma controllers. J Asthma. 2019;56(2):190–199. doi:10.1080/02770903.2018.143995429565708
   PubMed Web of Science ®Google Scholar
• Guo JJ, Kelton CM, Tsai K, Cai B, Bian B, Wigle PR. PRS30 inhaled corticosteroid and long-acting beta-agonist medication compliance in patients with moderate and severe asthma. Value Health. 2012;15(4):A57. doi:10.1016/j.jval.2012.03.314
   Web of Science ®Google Scholar
• Hagiwara M, Delea TE, Stanford RH. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powd. J Asthma. 2013;50(3):287–295. doi:10.3109/02770903.2012.75402823305687
   PubMed Web of Science ®Google Scholar
• Hardtstock F, Maywald U, Timmermann H, Unmuessig V, Mueller S, Wilke T. Prs70 applying different measures to assess patients’ non-adherence: results of a linked data study of patients with asthma in Germany. Value Health. 2019;22:S885. doi:10.1016/j.jval.2019.09.2559
   Web of Science ®Google Scholar
• Kelloway JS, Wyatt R, DeMarco J, Adlis S. Effect of salmeterol on patients’ adherence to their prescribed refills for inhaled corticosteroids. Ann Allergy Asthma Immunol. 2000;84(3):324–328. doi:10.1016/S1081-1206(10)62781-010752917
   PubMed Web of Science ®Google Scholar
• Navaratnam P, Friedman HS, Urdaneta E. Treatment with inhaled mometasone furoate reduces short-acting β2 agonist claims and increases adherence compared to fluticasone propionate in asthma patients. Value Health. 2011;14(2):339–346. doi:10.1016/j.jval.2011.01.00121402302
   PubMed Web of Science ®Google Scholar
• Makhinova T, Barner JC, Richards KM, Rascati KL. Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas Medicaid patients with persistent asthma. J Manag Care Pharm. 2015;21(12):1124–1132.
   PubMed Web of Science ®Google Scholar
• Papi A, Ryan D, Soriano JB, et al. Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma. J Allergy Clin Immunol Pract. 2018;6(6):1989–1998.e3. doi:10.1016/j.jaip.2018.03.00829627457
   PubMed Web of Science ®Google Scholar
• Sicras-Mainar A, Huerta A, Sánchez D, Navarro-Artieda R. Use of resources and costs associated with non-adherence to inhaled corticosteroid treatment in asthma. Semergen. 2018;44(1):13–22. doi:10.1016/j.semerg.2017.03.00528456499
   PubMedGoogle Scholar
• Souverein PC, Koster ES, Colice G, et al. Inhaled corticosteroid adherence patterns in a longitudinal asthma cohort. J Allergy Clin Immunol Pract. 2017;5(2):448–456.e2. doi:10.1016/j.jaip.2016.09.02227815064
   PubMed Web of Science ®Google Scholar
• Stern L, Berman J, Lumry W, et al. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol. 2006;97(3):402–408. doi:10.1016/S1081-1206(10)60808-317042149
   PubMed Web of Science ®Google Scholar
• Taylor A, Chen LC, Smith MD. Adherence to inhaled corticosteroids by asthmatic patients: measurement and modelling. Int J Clin Pharm. 2014;36(1):112–119. doi:10.1007/s11096-013-9862-024293333
   PubMed Web of Science ®Google Scholar
• Svedsater H, Parimi M, Ann Q, Gray C, Nixon M, Boxall N. A retrospective database study of persistence abd adherence in patients with asthma in the UK (UK-THIN): Fluticasone furoate/Vilanterol (FF/ VI) versus Beclometasone Dipropionate/Formoterol (BDP/FM). In: Thorax-2019-Btsabstracts2019372. BMJ Publishing Group Ltd; 2019:A1–A262.
   Google Scholar
• Vaidya V, Tak S, Hong SH. Impact of patient cost sharing on medication adherence among asthmatic patients on dual-controller therapy. J Pharm Health Serv Res. 2013;4(4):227–233. doi:10.1111/jphs.12035
   Google Scholar
• van Boven JFM, Koponen M, Lalic S, et al. Trajectory analyses of adherence patterns in a real-life moderate to severe asthma population. J Allergy Clin Immunol Pract. 2020;8:1961–1969.e6. doi:10.1016/j.jaip.2019.12.00231857262
   PubMed Web of Science ®Google Scholar
• Williams S, Trudo F, Suchower L, et al. Is history of patient adherence to asthma controller medication associated with initial choice of prescription for inhaled corticosteroid and long-acting β2-adrenergic agonist combination therapy? J Manag Care Pharm. 2012;18(7):551.
   Google Scholar
• Vervloet M, van Dijk L, Spreeuwenberg P, et al. The relationship between real-world inhaled corticosteroid adherence and asthma outcomes: a multilevel approach. J Allergy Clin Immunol Pract. 2020;8(2):626–634. doi:10.1016/j.jaip.2019.09.00331541763
   PubMed Web of Science ®Google Scholar
• Wu AC, Butler MG, Li L, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015;12(2):161–166. doi:10.1513/AnnalsATS.201410-459OC25569765
   PubMed Web of Science ®Google Scholar
• Woodcroft K, Yu Y. Inhaled corticosteroid and inhaled corticosteroid/long- acting beta agonist adherence and exacerbations among patients with persistent asthma in an integrated healthcare system. J Manag Care Spec Pharm. 2016;22:S65–6.
   Google Scholar
• Zhang S, Dang-Tan T, Ismaila A, et al. The impact of adherence and exacerbation frequency on health care utilization and associated direct costs in severe asthma. Chest. 2016;150(4):827A. doi:10.1016/j.chest.2016.08.927
   Web of Science ®Google Scholar
• Averell CM, Stanford RH, Laliberté F, Wu JW, Germain G, Duh MS. Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs. J Asthma. 2019;1–10. doi:10.1080/02770903.2019.1663429
   Web of Science ®Google Scholar
• Backer V, Stensen L, Sverrild A, Wedge E, Porsbjerg C. Objective confirmation of asthma diagnosis improves medication adherence. J Asthma. 2018;55(11):1262–1268. doi:10.1080/02770903.2017.141083029278942
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, Christensen DB. A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use. J Asthma. 2001;38(1):91–98. doi:10.1081/JAS-10000002611256559
   PubMed Web of Science ®Google Scholar
• Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C, Ducharme FM. Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence. Eur J Clin Pharmacol. 2017;73(1):91–97. doi:10.1007/s00228-016-2139-527695918
   PubMed Web of Science ®Google Scholar
• Blais L, Kettani FZ, Beauchesne MF, Lemière C, Perreault S, Forget A. New measure of adherence adjusted for prescription patterns: the case of adults with asthma treated with inhaled corticosteroid monotherapy. Ann Pharmacother. 2011;45(3):335–341. doi:10.1345/aph.1P71921386018
   PubMed Web of Science ®Google Scholar
• Covvey JR, Mullen AB, Ryan M, et al. A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom. Int J Clin Pract. 2014;68(10):1200–1208. doi:10.1111/ijcp.1245124797899
   PubMed Web of Science ®Google Scholar
• D’Ancona G, Kavanagh J, Roxas C, et al. Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma. Eur Respir J. 2020;55:1–7. doi:10.1183/13993003.02259-2019
   Web of Science ®Google Scholar
• Vaidya V, Gabriel MH, Patel P, Gupte R, James C. The impact of racial and ethnic disparities in inhaled corticosteroid adherence on healthcare expenditures in adults with asthma. Curr Med Res Opin. 2019;35(8):1379–1385. doi:10.1080/03007995.2019.158622130793988
   PubMed Web of Science ®Google Scholar
• Blais L, Vilain A, Kettani FZ, et al. Accuracy of the days’ supply and the number of refills allowed recorded in Quebec prescription claims databases for inhaled corticosteroids. BMJ Open. 2014;4(11):1–8. doi:10.1136/bmjopen-2014-005903
   Web of Science ®Google Scholar
• Korgaonkar S, Banahan B, Pittman E, Noble S. Effect of depression on adherence to controller medications and healthcare resource utilization in asthma patients. Value Health. 2018;21:S231. doi:10.1016/j.jval.2018.04.1567
   Web of Science ®Google Scholar
• Martin R, Price D, Krishnan J, et al. Excess inhaled corticosteroid adherence may be a marker of uncontrolled asthma. Eur Respir Soc Ann Congress. 2013;2013:10–11.
   Google Scholar
• Williams KL, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid non-adherence. J Allergy Clin Immunol. 2011;128(6):1185–1191. doi:10.1016/j.jaci.2011.09.01122019090
   PubMed Web of Science ®Google Scholar
• Visaria J, Frazee S, Henderson R. Is it appropriate to measure asthma controller adherence using pharmacy claims data? Value Health. 2012;15(4):A61–2. doi:10.1016/j.jval.2012.03.339
   Web of Science ®Google Scholar
• Belhassen M, Nolin M, Ginoux M, Van GE. Adherence to inhaled corticosteroids before and after an asthma-related hospitalisation: distinct trajectories. Eur Respir J. 2018;52:PA4478.
   Web of Science ®Google Scholar
• Dima A, Souverein P, Koster E, Chisholm A, Price D, Gene C. REG study: real-life, longitudinal ICS adherence patterns in a UK asthma population. Eur Respir J. 2015;2015:PA1238.
   Google Scholar
• Souverein P, Koster E, Dima A, Colice G. Longitudinal inhaled corticosteroid adherence using multiple methods to calculate medication possession ratios. Pharmacoepidemiol Drug Saf. 2015;24:1–587. doi:10.1002/pds.3838
   Web of Science ®Google Scholar
• Barner J. Medication Adherence: Focus on Secondary Database Analysis. ISPOR Student Forum; 2010.
   Google Scholar
• Sperber CM, Samarasinghe SR, Lomax GP. An upper and lower bound of the medication possession ratio. Patient Prefer Adherence. 2017;11:1469–1478. doi:10.2147/PPA.S13689028919719
   PubMed Web of Science ®Google Scholar
• Hudson M, Rahme E, Richard H, Pilote L. Comparison of measures of medication persistency using a prescription drug database. Am Heart J. 2007;153(1):59–65. doi:10.1016/j.ahj.2006.10.018
   Web of Science ®Google Scholar
• Gue ´nette L, Moisan J, Pre ´ville M, Boyer R. Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records. J Clin Epidemiol. 2005;58(9):924–933. doi:10.1016/j.jclinepi.2005.02.00216085196
   PubMed Web of Science ®Google Scholar
• Patel N. The difference between primary measures of medication adherence: PDC and MPR; 2018. Available from: https://www.usciences.edu/blog/noteworthy/posts/the-difference-between-primary-measures-of-medication-adherence-pdc-and-mpr.html. Accessed October 6, 2021.
   Google Scholar
• Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–1288. doi:10.1345/aph.1H01816868217
   PubMed Web of Science ®Google Scholar
• Bonafede M, Johnson B, Tang D, Shah N, Harrison D, Collier D. Etanercept-methotrexate combination therapy initiators have greater adherence and persistence than triple therapy initiators with rheumatoid arthritis. Arthritis Care Res. 2015;67:1656–1663. doi:10.1002/acr.22638
   Web of Science ®Google Scholar
• Chu L, Kawatkar A, Gabriel S. Medication adherence and attrition to biologic treatment in rheumatoid arthritis patients. Clin Ther. 2015;37:660–666. doi:10.1016/j.clinthera.2014.10.02225618317
   PubMed Web of Science ®Google Scholar
• Boulet L, Vervloet D, Magar Y, et al. Adherence: the goal to control asthma. Clin Chest Med. 2012;33:405–417. doi:10.1016/j.ccm.2012.06.00222929091
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Adherence to long-term therapies: evidence for action. World Health Organization; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed October 6, 2021.
   Google Scholar